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Abstract In vertebrates cytokines mediate innate (natural)
immunity and protect them against viral infections. The cytokine
interferon causes the induction of the (2P-5P)oligoadenylate
synthetase [(2-5)A synthetase], whose product, (2P-5P)oligoade-
nylate, activates the endoribonuclease L which in turn degrades
(viral) RNA. Three isoforms of (2-5)A synthetases exist, form I
(40^46 kDa), form II (69 kDa), and form III (100 kDa). Until
now (2-5)A synthetases have only been cloned from birds and
mammals. Here we describe the cloning of the first putative
invertebrate (2-5)A synthetase from the marine sponge Geodia
cydonium. The deduced amino acid sequence shows signatures
characteristic for (2-5)A synthetases of form I. Phylogenetic
analysis of the putative sponge (2-5)A synthetase indicates that it
diverged first from a common ancestor of the hitherto known
members of (vertebrate) (2-5)A synthetases I, (2-5)A synthetases
II and III. Moreover, it is suggested that the (2-5)A synthetases
II and III evolved from this common ancestor (very likely) by
gene duplication. Together with earlier results on the existence of
the (2P-5P)oligoadenylates in G. cydonium, the data presented
here demonstrate that also invertebrates, here sponges, are
provided with the (2-5)A system. At present, it is assumed that
this system might be involved in growth control, including control
of apoptosis, and acquired its additional function in innate
immune response in evolutionarily younger animals, in verte-
brates.
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1. Introduction
The evolution of immunology has been widely neglected
until today [1] especially in the taxon of invertebrates, even
though more than 95% of all known species belong to this
group [2]. Two mechanisms of immunity have been studied
extensively in vertebrates, the adaptive immune response and
the innate (natural) immune response (reviewed in [3]). Since
there is no evidence for the presence of a major histocompat-
ibility complex or high concentrations of circulating immuno-
globulins (Ig) in invertebrates, it is generally assumed that the
adaptive immune system is a vertebrate invention (reviewed in
[4]). However, recently advances have been made especially by
molecular biological approaches to detect at least some traits
of the latter system in invertebrates, e.g. the existence of mole-
cules revealing similarity to vertebrate antigen receptors in
tunicates [5], or the high polymorphism of the gene encoding
Ig-like domains of a receptor tyrosine kinase in sponges [6].
With the transition from unicellular to multicellular ani-
mals, defence mechanisms (i) against infection posed by for-
eign invaders and (ii) to distinguish self from non-self (re-
viewed in [7]) had to be developed. The biological model of
choice to study the origin of the metazoan immune system is
the sponges (Porifera), which represent the only extant meta-
zoan phylum that already existed prior to the ‘Cambrian ex-
plosion’ [8]. It was Metchniko¡ [9] who demonstrated that
echinoderm macrophage-like cells participate in host defence
by phagocytosis of foreign material as an early immune re-
sponse. It is now established that macrophages and monocytes
in mammals and hemocytes of invertebrates mediate many
innate immune responses to microbial infection (reviewed in
[10]). An innate immune system is activated when pathogens
bind to non-clonally distributed pattern recognition receptors
on immune cells [11]. Among those are the scavenger recep-
tor(s), which have been implicated both in vertebrate and in
invertebrate (insect) non-self recognition [12].
Recently, we reported that also in Porifera (the marine
sponge Geodia cydonium) an amazingly polymorphic system
of scavenger receptors, composed both of scavenger receptor
cysteine-rich domains of group A [13,14] and group B [15],
and of short consensus repeats [15], is present. These receptors
are located at the cell surface [14]. Biochemical evidence sug-
gests that invertebrate cytokine-related molecules, e.g. inter-
leukin in echinoderms [16], or tumor necrosis factor in
sponges [17], exist and may be involved in non-self recogni-
tion.
In the last 3 years our group has discovered that in tissue
from the sponge G. cydonium high levels of (2P-5P)oligoadenyl-
ates [(2-5)An] are synthesized [18]. In mammalian cells (2-5)An
is found after viral infections (reviewed in [19]). The oligomer
(2-5)An with a chain length of 29 n9 9 is synthesized from
ATP by the enzyme (2P-5P)oligoadenylate synthetase [(2-5)A
synthetase; EC 2.7.7.-] [20^22]. (2-5)An activates the endori-
bonuclease L [23,24] that consequently degrades RNA (re-
viewed in [25]). In vertebrate systems the expression of
(2-5)A synthetase is under control of interferons. These ini-
tiate a signal transduction pathway, via the interferon recep-
tors-JAK/STAT pathway (reviewed in [26]); ultimately the
transcription factor ISGF is bound to the ISRE elements,
which are located upstream of interferon-responsive genes,
thus activating their transcription [27]. Among the interfer-
on-responsive genes is the one which encodes (2-5)A synthe-
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tase [28]. Three isoforms have been described in mammalian
systems [20,29,30]: (2-5)A synthetase I corresponding to 40^
46 kDa, (2-5)A synthetase II with 69 kDa, and (2-5)A synthe-
tase III with 100 kDa. Forms I and II are present in the
nucleus and the mitochondria and are associated with the
microsomes [20]. The (2-5)A synthetases are known to be
activated by binding to double-stranded RNA (dsRNA) (re-
viewed in [31,32]). (2-5)A synthetase I has been cloned from
mouse [33,34], rat [22,35], human [36] and chicken [37]. (2-5)A
synthetase II has been isolated from human [38]; the 683 aa
long open reading frame (ORF) of the cDNA encoding (2-5)A
synthetase II is composed of two very similar parts [38].
(2-5)A synthetase III has been recently cloned also from hu-
man [39]; the p100 synthetase ORF is composed of three
adjacent synthetase domains and is presumably involved in
splicing of pre-messenger RNA.
Until now, (2-5)A synthetases have been identi¢ed enzy-
matically or by molecular cloning in vertebrates. In non-ver-
tebrate systems the product of (2-5)A synthetase, (2-5)An, has
only been unequivocally characterized in the sponge G. cydo-
nium by both biochemical and immunological methods [18]
and recently also by matrix-assisted laser desorption-ioniza-
tion time-of-£ight and nuclear magnetic resonance analyses as
well [40]. The activity of the enzyme (2-5)A synthetase was
also identi¢ed in G. cydonium [18].
Here we describe the cloning of a ¢rst putative invertebrate
(2-5)A synthetase, identi¢ed in the sponge G. cydonium, and
provide evidence that the deduced amino acid sequence is the
predecessor of the present-day (2-5)A synthetases I, as well as
of the two segments of (2-5)A synthetase II or the three do-
mains in the (2-5)A synthetase III.
2. Materials and methods
2.1. Materials
Restriction endonucleases and other enzymes for recombinant
DNA techniques and vectors were obtained from Stratagene (La Jol-
la, CA, USA), Qiagen (Hilden, Germany), Boehringer (Mannheim,
Germany), USB (Cleveland, OH, USA), Amersham (Buckingham-
shire, UK) and Promega (Madison, WI, USA).
2.2. Sponge
Specimens of G. cydonium [Jameson] (Metazoa; Porifera, Demo-
spongiae, Tetractinomorpha, Astrophorida, Geodiidae) were collected
near Rovinj (Croatia) from a depth of 25 m at 17‡C from their
habitat, the muddy sand bottoms. They were kept in aquaria in Mainz
(Germany) for up to 8 months at a temperature of 16‡C.
2.3. Isolation of a cDNA encoding the putative G. cydonium (2-5)A
synthetase
The complete sponge GC2-5AS cDNA was cloned by polymerase
chain reaction (PCR) from the G. cydonium cDNA library in VZAP
Express [41]. The degenerate reverse primer 5P-YGY HGG RTY IGC
IGG RTC-3P (where I = inosine, Y = T/C, H = T/A/C, R = A/G) in
conjunction with the ZAPII 5P-end vector-speci¢c forward primer
T3 was used. The degenerate primer was designed against the con-
served amino acid (aa) segment in the mouse (2-5)A synthetase I ([33];
accession number P11928) of signature 2, between aa302 and aa307
(DPADPT). The PCR reaction was carried out using a GeneAmp
9600 thermal cycler with initial denaturation at 95‡C for 3 min,
then 35 ampli¢cation cycles of 95‡C for 30 s, 60‡C for 45 s, 74‡C
for 1.5 min, and a ¢nal extension step at 74‡C for 10 min. The
reaction mixture was as described earlier [42]. A fragment of V900
bp was used to isolate the cDNA [43]. The longest insert obtained had
a size of 1141 nt (excluding the poly(A) tail). The clone was termed
GC2-5AS (Y18497) and was sequenced using an automatic DNA
sequenator (Li-Cor 4200).
2.4. Sequence comparisons
Analyses of the sequence composition, structure and features were
performed by the computer programs PC/GENE [44]. Homology
searches and sequence retrieval were done via the E-mail servers at
the European Bioinformatics Institute, Hinxton Hall, UK (BLITZ@
ebi.ac.uk) and the National Center for Biotechnology Information,
National Institutes of Health, Bethesda, MD, USA (BLAST@
ncbi.nlm.nih.gov). A phylogenetic tree was constructed on the basis
of aa sequence alignment by neighbor joining [45] applying the PHY-
LIP ver. 3.5c program [46]; the distance matrix was calculated as
described [47]. The degree of support for internal branches was further
assessed by bootstrapping [46]. Graphical output of the bootstrap
¢gure was produced by the program ‘Treeview’ (Roderic D.M.
Page, University of Glasgow, UK; http://taxonomy.zoology.gla.
ac.uk/rod/treeview.html). Multiple alignment ^ with the default op-
tions (gap opening: 10.00; gap extension: 0.05; delay divergent se-
quence: 40%; Blossum series; gap separation distance: 8) ^ was per-
formed with CLUSTAL W version 1.6 [48], and the graphic
presentation was composed with GeneDoc [49]. The automatic align-
ment was optimized manually.
Hydropathy analysis, based on the method of Kyte and Doolittle
[50], was performed using the PC/GENE Soap [44].
2.5. Northern blot
RNA was extracted from liquid nitrogen-pulverized sponge tissue
with TRIzol Reagent (Gibco BRL) and the procedure for Northern
blot analysis on Hybond N membrane was performed as described
[42]. Hybridization experiments were done with the complete cDNA
for (2-5)A synthetase from G. cydonium, GC2-5AS, as a probe. The
probe was labeled with DIG-11-dUTP by the DIG DNA labeling kit.
After hybridization the DIG-labeled nucleic acid was detected with
anti-DIG Fab fragments (conjugated to alkaline phosphatase) and
visualized by the chemiluminescence technique using CDP, the chemi-
luminescence substrate alkaline phosphatase, according to the instruc-
tions of the manufacturer (Boehringer).
3. Results and discussion
3.1. Cloning of a cDNA encoding the putative (2-5)A
synthetase from G. cydonium
Applying a degenerate reverse primer, designed against one
conserved region of the (2-5)A synthetase I (see Section 2) a
fragment of V900 bp was obtained. The complete cDNA,
GC2-5AS, 1141 nt in length (EMBL accession number
Y18497) encoding the putative sponge (2-5)A synthetase was
isolated by primer walking. The size of the transcript was 1.3
kb (Fig. 1), indicating that the complete cDNA was obtained.
The ¢rst ATG, position 79, starts the ORF of 981 bp. The
ATG codon is surrounded by a medium strong Kozak con-
sensus sequence which in GC2-5AS reads GATATGG (the
start codon is in bold) [51].
Fig. 1. Northern blot analysis of GC2-5AS. Two (lane a), four (lane
b) and six Wg (lane c) of G. cydonium total RNA were electrophor-
esed through 1% formaldehyde/agarose gel, blotted and hybridized
to the DIG-labeled GC2-5AS. Left: Molecular weight markers (M;
in kb).
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3.2. The deduced aa sequence
The deduced 327 long aa sequence from the ORF termed
25A_GEOCY has a calculated peptide mass of 37 400 Da and
an isoelectric point of 9.6 ([44]; Physchem program). The
putative sponge (2-5)A synthetase displays the two conserved
motifs ^ of unknown function [52] ^, signature 1 between
aa206 and aa217 [Y(A/L)(L/I)xLL(T/V)(V/I)(Y/K) A(Y/W)(E/
N)] and signature 2 between aa270 and aa280 [RPx(I/V)(L/
I)DPA(D/N)P (T/A)] (Fig. 2). The P-loop motif [53] in the
sponge sequence (aa49 to aa59) di¡ers in one position at aa52
where glycine is replaced by alanine. The other segment of
(2-5)A synthetase essential for enzyme activity [34,54], resi-
dues aa285 to aa296, which binds to ATP, is also present in
the sponge sequence (Fig. 2). By progressive deletion mutation
[34] the dsRNA binding region of (2-5)A synthetase has been
detected between aa104 and aa158 of the murine enzyme or aa95
and aa143 in the sponge sequence. The sponge sequence has
been aligned with the mouse and the chicken (2-5)A synthe-
tases I; the conserved regions among all three are highlighted
in Fig. 2.
Homology searches (BLITZ and BLAST) with the
25A_GEOCY deduced protein revealed highest similarity to
(2-5)A synthetases I. The sponge sequence shares the
following percentages of identical aa (similar, including
identical, aa) with the two vertebrate sequences: (2-5)A syn-
thetase from mouse (accession number P11928) 18% (39%),
and (2-5)A synthetase from chicken (AB002586) 17% (37%)
(Fig. 2).
In order to further support the high similarity between the
putative sponge (2-5)A synthetase and the mammalian (2-5)A
synthetases a hydropathy analysis was performed. The puta-
tive sponge (2-5)A synthetase shows hydrophobic peaks for
the P-loop motif, the potential ATP binding region, the
dsRNA binding segment, and the two conserved (2-5)A syn-
thetase signatures at the positions that are also prominent in
the murine sequence (data not shown).
3.3. Phylogenetic analysis and evolution of (2-5)A synthetases
Based on sequence comparisons, and on polypeptide
lengths, it has been concluded that the (2-5)A synthetase II
is composed of two segments which both are similar to (2-5)A
synthetase I [38]. Therefore, the human 69 kDa (2-5)A syn-
thetase II sequence (accession number M87284) was cut at
position aa336 into two segments; both parts were aligned
with the putative sponge (2-5)A synthetase, belonging to class
I (Fig. 3A). The identity of the sponge sequence to the NH2-
or COOH-terminus of the human (2-5)A synthetase II is 16%
or 17%, while the respective similarities (including the identi-
cal aa) were 29% or 33%.
An unrooted phylogenetic tree was constructed with the
putative sponge (2-5)A synthetase as well as the two segments
of the human (2-5)A synthetase II, the sequences from mouse,
Fig. 2. Alignment of the deduced aa sequence of the G. cydonium putative (2-5)A synthetase, 25A_GEOCY (Y18497), with the corresponding
proteins from mouse (25A_MOUSE, accession number P11928 [33]) as well as from chicken (25A_CHICK, AB002586 [37]). The sequences
were truncated as follows: mouse at aa 366 and chicken at aa 355. The alignment was performed using the CLUSTAL W program. Amino
acid residues similar among all three sequences are in inverted type and residues conserved in at least two sequences are shaded. The character-
istic signatures of the (2-5)A synthetase are indicated: the two conserved signatures (Sig-1 and Sig-2), the P-loop motif (P-loop), the potential
ATP binding region (ATP) and the dsRNA binding segment (Bdg: dsRNA).
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pig, rat, human and chicken (2-5)A synthetases I and the
human (2-5)A synthetase-like protein. In addition, the three
adjacent synthetase domains of the human (2-5)A synthetase
III [39] were included (Fig. 3B). The result shows that the
putative sponge (2-5)A synthetase originates from a node
from which also the domains of the (2-5)A synthetases I^III
and the human (2-5)A synthetase-like molecule derive. All
mammalian (2-5)A synthetases I fall into one cluster, while
the domains of the (2-5)A synthetases II and III and the
chicken enzyme form separate groups (Fig. 3B).
Until now, in invertebrates only the G. cydonium putative
(2-5)A synthetase cDNA, described here, could be identi¢ed.
The sponge molecule shares a common ancestor with the
members of the vertebrate (2-5)A synthetases of isoform I;
Fig. 3. Relationship between (2-5)A synthetases I, II and III to the sponge putative (2-5)A synthetase sequence (Y18497). A: Alignment of the
putative sponge (2-5)A synthetase, 25A_GEOCY, with the two segments of the human (2-5)A synthetase II (25AII_HS, M87284 [38]); the hu-
man sequence was cut at position aa336, and the NH2-terminal part (25AII_HS-N) and the COOH-terminus (25AII_HS-C) were aligned with
the sponge sequence. B: Unrooted phylogenetic tree, constructed from the putative sponge (2-5)A synthetase sequence (25A_GEOCY) and
(i) with the group of mammalian (2-5)A synthetases I: mouse (25A_MOUSE; P11928), pig (25A_PIG; AJ225090), rat (25A_RAT; 461431)
and human (25A_HUMAN; P00973) as well as the chicken (2-5)A synthetase (25A_CHICK; AB002586), (ii) the second group, the (2-5)A syn-
thetase II and the related molecules: the two parts of the human (2-5)A synthetase II (25AII_HS-N and 25AII_HS-C; accession number
M87284) as well as the human (2-5)A synthetase-like protein (25A-L_HUMAN; AJ225089) and (iii) the three domains of the human (2-5)A
synthetase III (25A-100_HUMAN; AAD28543). The three domains of synthetase III are delimited as described [39] and have been termed
25A-100_HUMAN-I to -III. The analysis was performed by neighbor joining as described in Section 2. The numbers at the nodes are an indi-
cation of the level of con¢dence for the branches as determined by bootstrap analysis (1000 bootstrap replicates). The scale bar indicates an
evolutionary distance of 0.1 aa substitutions per position in the sequence.
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17^20% identical aa (33^39% similar, including identical, aa)
are recorded (Fig. 4). We suggest that in the course of evolu-
tion the ancestral molecule duplicated and gave rise to the
ancestor of the (2-5)A synthetase II (Fig. 4). The sponge syn-
thetase has 16% (17%) identical aa within the NH2-terminus
(COOH-terminus) and 29% (33%) similar aa to the human
(2-5)A synthetase II. In a further stage an additional synthe-
tase unit was formed; this molecule gave rise to the (2-5)A
synthetase III. The similarity of the sponge sequence to the
two COOH-terminal units of the human (2-5)A synthetase III
is higher than to that of the NH2-terminus. Since the similar-
ity of the two COOH-terminal units of synthetase III to each
other and also to the COOH-terminal unit of (2-5)A synthe-
tase II is high, it is likely that a duplication occurred at the
COOH-terminus of the ancestor of synthetase II. This con-
clusion is also supported by the calculation presented earlier
[39]. The duplication process resulting in the evolution of the
present-day (2-5)A synthetase II might have occurred V310
million years ago (based on the percentage of divergent aa
and the estimated evolutionary rate deduced from the human
and chicken enzymes [55^57]; 36% identical aa exist between
the human synthetase I and the NH2-terminus of the human
(2-5)A synthetase II).
In an earlier study it was estimated that the G. cydonium
galectin molecule diverged from a common metazoan ancestor
800 million years ago [40,58]; recently paleontological data
demonstrated the existence of sponges already 580 million
years ago [59]. The time of the ¢rst duplication, based on
the calculation presented here, was 310 million years ago,
hence later in evolution than the Cambrian explosion, which
is dated back to 530 million years ago [8].
4. Conclusion
It is well established that multicellular animals are of mono-
phyletic origin as shown by the examples of the receptor ty-
rosine kinase [60] and the integrin receptors [42]; these are
autapomorphic characters restricted to all Metazoa including
Porifera [61]. Until this study (2-5)A synthetases had only
been cloned from vertebrates; now a putative (2-5)A synthe-
tase was found also in a sponge. Future studies will show if
the existence of this enzyme, or enzyme family, is restricted to
Metazoa. In Caenorhabditis elegans no (2-5)A synthetase gene
has been found during the genome project (www.The Sanger
Centre Web Server.ac.uk).
All hitherto known (2-5)A synthetases are stimulated by
interferon (reviewed in [62]). The (2-5)A system protects
against virus infection [63] and plays a role in growth suppres-
Fig. 4. Proposed branching order of the putative sponge (2-5)A synthetase (25A SY) from a common ancestor of metazoan (2-5)A synthetases
(ancestor: 25A SY). The sponge synthetase, 25A_GEOCY, splits o¡ ¢rst from this common ancestor. Later in evolution the vertebrate (2-5)A
synthetases I branch o¡; they are more closely related to the sponge molecule than any of the single domains present in the synthetases II and
III. Subsequently, the ancestral (2-5)A synthetase underwent gene duplication and gave rise to the evolution of (2-5)A synthetases of group II,
with the two termini, 25A SY-II (NH2-ter) and 2-5A SY-II (COOH-ter). From this level, a second process of domain addition, very likely du-
plication of the COOH-terminal unit, occurred, resulting in the formation of the synthetases III which comprise three synthetase domains. The
percentages of aa identity and conservative aa homology (in parentheses) between the domains of the vertebrate synthetases I^III and the puta-
tive sponge synthetase are given.
FEBS 22912 18-11-99
M. Wiens et al./FEBS Letters 462 (1999) 12^1816
sion [64]. Recently, experiments have been presented which
indicate that the (2-5)A system is involved in apoptosis [65].
Based on the di¡erent roles of the (2-5)A system it can be
proposed that in sponges in an early stage of evolution this
mechanism was involved in growth control, including control
of apoptosis. Later, in vertebrates, the (2-5)A system acquired
a further function related to immunology (reviewed in [19]). It
has been suggested [65] that growth suppression and apoptosis
contribute to the antiviral activity displayed by the (2-5)A
system; this (these) function(s) have been attributed also to
the (2-5)A synthetase-like protein [52]. Future studies must
show if an interferon-like antiviral system which also involves
the (2-5)A synthetase exists in sponges as well. It should be
stressed that experimental evidence is available for the expo-
sure of sponges to virus loads [66].
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